Latest Period
Q4 2025
CUSIP: 92189F387
Latest Period
Q4 2025
Institutions Reporting
144
Shares (Excl. Options)
10,939,356
Price
$22.91
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
Latest holder context comes from 144 institutions filings for Q4 2025.
What is CUSIP 92189F387?
CUSIP 92189F387 identifies SHYD - VANECK ETF TRUST - SHRT HGH YLD MUN in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Use the next link that matches the question you still need to answer about this security.
Open recent reporting periods for CUSIP 92189F387:
As of 31 Dec 2025, 144 institutional investors reported holding 10,939,356 shares of VANECK ETF TRUST - SHRT HGH YLD MUN (SHYD).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 1,104,779 | $25,028,567 | -$2,121,248 | $22.66 | 30 |
| 2025 Q4 | 10,939,356 | $250,622,167 | +$15,365,780 | $22.91 | 144 |
| 2025 Q3 | 10,199,713 | $233,510,155 | +$650,034 | $22.90 | 131 |
| 2025 Q2 | 10,126,619 | $228,720,824 | +$11,154,960 | $22.59 | 129 |
| 2025 Q1 | 9,566,858 | $215,125,672 | +$6,885,166 | $22.49 | 120 |
| 2024 Q4 | 9,396,480 | $211,258,799 | +$9,751,547 | $22.48 | 125 |
| 2024 Q3 | 8,909,672 | $202,402,767 | -$1,053,963 | $22.72 | 116 |
| 2024 Q2 | 8,875,499 | $198,528,389 | -$7,564,000 | $22.37 | 112 |
| 2024 Q1 | 9,168,215 | $205,427,631 | -$23,956,421 | $22.41 | 106 |
| 2023 Q4 | 10,278,899 | $227,451,634 | +$10,405,892 | $22.13 | 119 |
| 2023 Q3 | 9,718,105 | $210,090,133 | -$1,808,132 | $21.62 | 109 |
| 2023 Q2 | 9,756,447 | $217,568,386 | +$2,520,488 | $22.30 | 107 |
| 2023 Q1 | 9,623,412 | $214,519,159 | -$6,636,472 | $22.29 | 110 |
| 2022 Q4 | 9,923,778 | $221,171,485 | -$5,192,513 | $22.27 | 107 |
| 2022 Q3 | 10,064,832 | $219,273,531 | -$8,869,906 | $21.77 | 101 |
| 2022 Q2 | 10,421,287 | $234,148,365 | +$35,389,105 | $22.46 | 102 |
| 2022 Q1 | 8,820,177 | $205,232,466 | +$13,273,275 | $23.26 | 101 |
| 2021 Q4 | 8,141,253 | $204,743,214 | -$2,802,724 | $25.15 | 110 |
| 2021 Q3 | 8,148,102 | $204,518,481 | +$43,370,524 | $25.10 | 98 |
| 2021 Q2 | 6,418,663 | $162,311,214 | +$28,751,483 | $25.45 | 93 |
| 2021 Q1 | 5,277,974 | $132,091,961 | +$28,070,512 | $25.02 | 87 |
| 2020 Q4 | 4,152,598 | $103,004,254 | -$1,697,549 | $24.80 | 73 |
| 2020 Q3 | 4,212,793 | $102,677,662 | -$11,333,542 | $24.38 | 68 |
| 2020 Q2 | 4,667,416 | $111,213,168 | -$48,800,573 | $23.82 | 67 |
| 2020 Q1 | 6,496,591 | $146,248,835 | +$38,177,787 | $22.51 | 71 |
| 2019 Q4 | 5,012,099 | $126,326,193 | +$22,698,966 | $25.20 | 72 |
| 2019 Q3 | 4,376,431 | $110,199,083 | +$9,825,487 | $25.18 | 63 |
| 2019 Q2 | 3,953,833 | $99,007,328 | +$6,629,321 | $25.04 | 60 |
| 2019 Q1 | 3,742,501 | $92,440,015 | +$17,151,731 | $24.70 | 55 |
| 2018 Q4 | 3,028,375 | $73,385,143 | -$4,699,882 | $24.20 | 51 |
| 2018 Q3 | 2,875,953 | $69,911,719 | +$2,042,275 | $24.31 | 48 |
| 2018 Q2 | 2,791,046 | $68,420,934 | +$18,923,785 | $24.52 | 44 |
| 2018 Q1 | 1,998,408 | $48,376,265 | +$1,602,184 | $24.21 | 42 |
| 2017 Q4 | 1,932,326 | $46,757,129 | +$1,860,479 | $24.19 | 39 |
| 2017 Q3 | 1,847,931 | $45,198,000 | -$1,524,595 | $24.46 | 31 |
| 2017 Q2 | 1,910,512 | $46,386,000 | -$4,439,837 | $24.28 | 36 |
| 2017 Q1 | 2,094,438 | $50,279,000 | -$20,757,757 | $24.01 | 34 |
| 2016 Q4 | 2,960,434 | $70,417,000 | +$9,324,620 | $23.79 | 36 |
| 2016 Q3 | 2,269,302 | $57,301,000 | +$4,821,082 | $25.25 | 24 |
| 2016 Q2 | 2,139,169 | $54,435,000 | +$52,772,710 | $25.45 | 28 |
| 2016 Q1 | 61,538 | $1,530,000 | +$718,000 | $24.88 | 2 |